Solid growth driven by Industrial Measurements Vaisala reported its Q2 results, which with the preliminary figures given ahead of the quarte...
Q2: Net sales up 37% y-o-y, EBIT margin of 4.6% (1.
Redeye is encouraged by solid gross margins and clearly lower Opex than we expected.
Redeye will likely increase its Base case and forecasts following a Q2 report, beating our EBIT forecasts by 9%.
Redeye concludes that Q2 exceeded our expectations.
Yesterday, Vitruvian Partners invested NOK 420m in a private placement, making the private equity fi...
Högre priser börjar få genomslag i resultatet Rottneros rapporterade EBIT om 97 mkr i Q2'21, att jämföra med 2 mkr i Q2'20 och 11 mkr i Q1'2...
Tydliggör i rubrik att det är en analys från Penser Access Stark rapport Omsättningen i Q2 uppgick t...
Stark rapport Omsättningen i Q2 uppgick till 46,4 mkr vs våra estimat om 36,4 mkr.
Redeye takes a neutral stance to Sdiptech following a solid Q2 report with strong growth, organic and from M&A, and an EBITA in line with ou...
Redeye remains with a Base case below the current share price, despite raising our forecasts and Bas...
Key takes from the Q2’21 report Midsona’s Q2 report was on the softer side.
Entering phase 3: leveraging economies of scale As 24Storage management has repeatedly communicated,...
Q2e: Sales up 17% y-o-y, EBIT margin 11.3% SJR preannounced on 12 July that the result for Q2 exceed...
All key markets saw strong sales recovery in Q2’21 Ôssur reported a strong Q2’21 with sales of USD 190m (vs.
Q2 details Q1 seemingly marked the trough as CTT was able to deliver Q2 sales of SEK 38m (+1% vs.
Relais updated its financial targets in May, with a EUR 500m top-line target by 2026 on a pro forma ...
Sdiptech delivered a solid report above our expectations.
Consti's net sales in Q2 amounted to EUR 70.9m, in line with our and consensus estimates (EUR 68.
Q2 well in line with our expectations Innofactor reported its Q2 results, which were well in line wi...
Calliditas Therapeutics har tecknat ett samarbetsavtal med STADA för läkemedelskandidaten Nefecon på den europeiska marknaden.
Badrumskoncernen Svedbergs fortsätter att leverera stark tillväxt och kraftiga resultatförbättringar...
Redeye sees a solid Q2 from Sdiptech, with strong organic sales growth, somewhat soft margins, and a...
SDS publicerade idag den 22 juli 2021 sin delårsrapport för andra kvartalet 2021.
Sdiptech’s Q2 2021 report was overall ahead of our estimates, driven by both focus segments Water & ...
The German private company Stada is, in our view, a resourceful partner with a strategic interest in...
Tillväxt y/y Arises omsättning i Q2 uppgick till 36 mkr (30) och EBITDA 12 mkr (6).
Lönsam tillväxt på rekordnivåer Plejd redovisade en nettoomsättning för det andra kvartalet 2021 mot...
Actic Group, a leading northern-European fitness club operator, reported Q2 sales in line with our e...
